Hjem › Mage-tarmkreft › North Carolina
Kliniske studier for Mage-tarmkreft i North Carolina
11 studier for Mage-tarmkreft søker deltakere på steder i North Carolina.
Byer i North Carolina
Offisiell studietekst (engelsk)
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
- FirstHealth of the Carolinas-Moore Regional Hospital, Pinehurst
RekruttererFrivillige helsepersonell ønskes velkommen
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT07283939Surgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Network, STOP-VTE Study
- FirstHealth of the Carolinas-Moore Regional Hospital, Pinehurst
- Wake Forest NCORP Research Base, Winston-Salem
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT07215624Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- Duke Cancer Center Cary, Cary
- Duke Cancer Center - Investigational Chemotherapy Service, Durham
- Duke Cancer Center, Durham
- og 2 flere
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT07222800DESTINY-PANTUMOUR04
- Research Site, Durham
- Research Site, Wilson
RekruttererObservasjonsstudie
Alder 18 til 130 · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07124000A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy
- GSK Investigational Site, Charlotte
- GSK Investigational Site, Durham
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07218926Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
- Duke University Medical Center, Durham
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT06445062The Effects of SCFA Supplementation in Subjects Receiving Abdominopelvic RT: A Randomized Controlled Study
- Flora Danquah, Chapel Hill
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 3. sep. 2026 · NCT04700527A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)
- GSK Investigational Site, Durham
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 3. aug. 2026 · NCT06885034Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
- Duke Cancer Center, Durham
- Carolina BioOncology Institute, Huntersville
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 3. jun. 2026 · NCT06040541A Study of DB-1324 in Advanced/Metastatic Gastrointestinal Tumors
- USA01-0, Huntersville
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 22. mai 2026 · NCT07263594Disease Outcomes and Toxicities in Patients With Gastrointestinal and Sarcomatous Malignancies
- University of North Carolina at Chapel Hill, Department of Radiation Oncology, Chapel Hill
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 30. mar. 2026 · NCT05743426Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.